Pharma sector: Firms to clock 11% sales, EBITDA growth in Q1FY26 |...

Dununu.com Dununu

Sponsorluk

Pharma sector: Firms to clock 11% sales, EBITDA growth in Q1FY26

RSS Feed Business

Posted

55

India's pharmaceutical sector is projected to experience an 11% year-on-year growth in sales and EBITDA for Q1 FY26, driven by strong market performance across various regions. The hospital segment is expected to lead with a 17% growth, while diagnostics firms anticipate a 14% sales increase. Government initiatives and investments in R&D further support the industry's optimistic outlook.

Read Full Article

Please log in to like, share and comment!

Donald Trump releases tariff letters: Japan, Korea to face 25% duties on imports to US from August 1, 2025; check details

US President Trump has announced new tariff rates effective August 1, 2025, impacting trade...

By 0 1

Drone industry growth outlook: India’s manufacturing potential may hit $23 billion by 2030; Defence and agri sectors seen as key drivers, says Nexgen report

A new report by Nexgen Exhibitions projects India's drone industry could unlock $23 billion in...

By 0 1

Today’s News in a Nutshell

KATHMANDU: Khabarhub brings you a glimpse of major developments of the day in Nepal, including...

By 0 26

Gifts from Modi carry Ayodhya’s spiritual legacy and folk artistry abroad

By 0 25

Akash Deep: A Mohammed Rafi fan who once called cricket ‘ameeron ka khel,’ is now India’s hero

Akash Deep lost his father and elder brother in six months when he was 18. During the second wave...

By 0 25